Citra Borneo Utama Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Citra Borneo Utama Tbk. trades at Rp770 (market cap 2.41T, 1.4K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 3.66M 24h volume). The key difference: Citra Borneo Utama Tbk. is far larger — about 5.1× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (3.66M versus 1.4K). Which is the better fit depends on your goals.
| CBUT | PRDL | |
|---|---|---|
Market Cap | 2.41T | 470.58B |
Volume | 1.4K | 3.66M |
Lot | 14 | 36.58K |
Turnover | 1.07M | 965.26M |
Average Price | 766.07 | 263.88 |
Value | 1.07M | 965.26M |
Indicative Equilibrium Price | 770 | 272 |
Indicative Equilibrium Volume | 300 | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →